Opdivo Could Drive Bristol-Myers Squibb’s Revenue Growth in 2017

In 2Q17, Bristol-Myers Squibb’s (BMY) Opdivo generated revenues of around $1.2 billion, which reflected ~45% growth on a year-over-year basis.

Advertisement